213 related articles for article (PubMed ID: 30266933)
1. Clonal dynamics in osteosarcoma defined by RGB marking.
Gambera S; Abarrategi A; González-Camacho F; Morales-Molina Á; Roma J; Alfranca A; García-Castro J
Nat Commun; 2018 Sep; 9(1):3994. PubMed ID: 30266933
[TBL] [Abstract][Full Text] [Related]
2. RGB marking facilitates multicolor clonal cell tracking.
Weber K; Thomaschewski M; Warlich M; Volz T; Cornils K; Niebuhr B; Täger M; Lütgehetmann M; Pollok JM; Stocking C; Dandri M; Benten D; Fehse B
Nat Med; 2011 Apr; 17(4):504-9. PubMed ID: 21441917
[TBL] [Abstract][Full Text] [Related]
3. RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models.
Gambera S; Patiño-Garcia A; Alfranca A; Garcia-Castro J
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33919355
[TBL] [Abstract][Full Text] [Related]
4. Imaging the interaction of α
Tome Y; Kiyuna T; Uehara F; Bouvet M; Tsuchiya H; Kanaya F; Hoffman RM
J Cell Biochem; 2019 Jan; 120(1):283-289. PubMed ID: 30145815
[TBL] [Abstract][Full Text] [Related]
5. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
6. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
7. Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells.
Gambera S; Abarrategi A; Rodríguez-Milla MA; Mulero F; Menéndez ST; Rodriguez R; Navarro S; García-Castro J
Stem Cells; 2018 Oct; 36(10):1487-1500. PubMed ID: 30001480
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
Tieken C; Verboom MC; Ruf W; Gelderblom H; Bovée JV; Reitsma PH; Cleton-Jansen AM; Versteeg HH
Thromb Haemost; 2016 May; 115(5):1025-33. PubMed ID: 26763081
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
10. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
[TBL] [Abstract][Full Text] [Related]
11. Green fluorescent protein (GFP)-expressing tumor model derived from a spontaneous osteosarcoma in a vascular endothelial growth factor (VEGF)-GFP transgenic mouse.
Huang P; McKee TD; Jain RK; Fukumura D
Comp Med; 2005 Jun; 55(3):236-43. PubMed ID: 16089171
[TBL] [Abstract][Full Text] [Related]
12. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
[TBL] [Abstract][Full Text] [Related]
13. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
[TBL] [Abstract][Full Text] [Related]
14. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice.
Brennecke P; Arlt MJ; Muff R; Campanile C; Gvozdenovic A; Husmann K; Holzwarth N; Cameroni E; Ehrensperger F; Thelen M; Born W; Fuchs B
PLoS One; 2013; 8(9):e74045. PubMed ID: 24040160
[TBL] [Abstract][Full Text] [Related]
15. Multiplexing clonality: combining RGB marking and genetic barcoding.
Cornils K; Thielecke L; Hüser S; Forgber M; Thomaschewski M; Kleist N; Hussein K; Riecken K; Volz T; Gerdes S; Glauche I; Dahl A; Dandri M; Roeder I; Fehse B
Nucleic Acids Res; 2014 Apr; 42(7):e56. PubMed ID: 24476916
[TBL] [Abstract][Full Text] [Related]
16. Construction of a Tc1-like transposon Sleeping Beauty-based gene transfer plasmid vector for generation of stable transgenic mammalian cell clones.
Harris JW; Strong DD; Amoui M; Baylink DJ; Lau KH
Anal Biochem; 2002 Nov; 310(1):15-26. PubMed ID: 12413468
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-208a promotes osteosarcoma cell proliferation, migration, and invasion.
Qin F; Tang H; Zhang Y; Zhang Z; Huang P; Zhu J
J Cell Physiol; 2020 May; 235(5):4734-4745. PubMed ID: 31637737
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.
Eirew P; Steif A; Khattra J; Ha G; Yap D; Farahani H; Gelmon K; Chia S; Mar C; Wan A; Laks E; Biele J; Shumansky K; Rosner J; McPherson A; Nielsen C; Roth AJ; Lefebvre C; Bashashati A; de Souza C; Siu C; Aniba R; Brimhall J; Oloumi A; Osako T; Bruna A; Sandoval JL; Algara T; Greenwood W; Leung K; Cheng H; Xue H; Wang Y; Lin D; Mungall AJ; Moore R; Zhao Y; Lorette J; Nguyen L; Huntsman D; Eaves CJ; Hansen C; Marra MA; Caldas C; Shah SP; Aparicio S
Nature; 2015 Feb; 518(7539):422-6. PubMed ID: 25470049
[TBL] [Abstract][Full Text] [Related]
19. The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
Shekhar R; Priyanka P; Kumar P; Ghosh T; Khan MM; Nagarajan P; Saxena S
J Biol Chem; 2019 Mar; 294(12):4381-4400. PubMed ID: 30679313
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
